XML 21 R9.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders' Equity and Share-Based Compensation | 9 Months Ended
--- | ---
Sep. 27, 2025
Stockholders' Equity and Share-Based Compensation |
Stockholders' Equity and Share-Based Compensation | Note 3 – Stockholders’ Equity and Share-Based Compensation Common Stock Issuance On September 8, 2025, the Company entered into a Purchase Agreement with certain investors. The Company issued and sold an aggregate of 10,319,727 shares of common stock, par value $0.001 per share, resulting in gross proceeds of $10,733. Options and Restricted Stock Units The Company had the following common stock option activity during the thirty-nine weeks ended September 27, 2025:
| ● | Granted options to purchase 100 common shares.
| ● | Exercise of 0 options to purchase common shares.
| ● | Forfeiture of 0 options to purchase common shares.
| ● | Expiration of 245 options to purchase common shares.
The following table summarizes the Company’s restricted stock unit ("RSU") and restricted stock award (“RSA”) activity for the thirty-nine weeks ended September 27, 2025, and details regarding the awards outstanding and exercisable as of September 27, 2025 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Weighted Average | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | Grant Date | ​ | Aggregate
​ |  | Shares |  |  | Fair Value |  | Intrinsic Value
Vested and expected to vest as of December 28, 2024 | ​ | 5,432 |  | ​ | ​ | ​ | ​ | ​
Awarded | ​ | 2,950 |  | ​ | ​ | ​ | ​ | ​
Vested | ​ | (1,800) |  | ​ | ​ | ​ | ​ | ​
Forfeited | ​ | (126) |  | ​ | ​ | ​ | ​ | ​
Awards outstanding, September 27, 2025 | ​ | 6,456 |  | $ | 3.04 |  | $ | 4,849
Vested and expected to vest as of September 27, 2025 | ​ | 6,456 |  | $ | 3.04 |  | $ | 4,849
​ During the thirty-nine weeks ended September 27, 2025, 1,800 RSUs that vested were time-based. For the thirteen and thirty-nine weeks ended September 27, 2025, we recorded compensation costs related to stock options, RSUs and RSAs of $2,472 and $8,119, respectively. For the thirteen and thirty-nine weeks ended September 28, 2024, we recorded compensation costs related to stock options and RSUs of $3,187 and $9,528, respectively. As of September 27, 2025, there was unrecognized compensation expense related to stock options, RSUs and RSAs of $7,954 that will be expensed through September 2029.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration